| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC1607 |
| Trial ID | NCT02742727 |
| Disease | Acute Myeloid Leukemia | Precursor T-Lymphoblastic Lymphoma/Leukemia | T-Cell Prolymphocytic Leukemia | T-Cell Large Granular Lymphocyte Leukemia |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CD7 CAR-NK cells |
| Generation | 3rd |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma |
| Year | 2016 |
| Country | China |
| Company sponsor | PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
| Other ID(s) | PG-107-002 |
| Cohort 1 | |||||||||
|
|||||||||